The tariff classification of Tramadol Hydrochloride (CAS-22204-88-2) in bulk form, from Italy
Issued August 8, 2008 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2922.50.2500
Headings: 2922
Product description
The subject product, Tramadol Hydrochloride, is an analgesic and is indicated for the management of moderate to severe pain.
CBP rationale
The applicable subheading for the Tramadol Hydrochloride in bulk form will be 2922.50.2500, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Oxygen-function amino-compounds: Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function: Aromatic: Other: Drugs: Other: Other.
Full text
N034996 August 8, 2008 CLA-2-29:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 2922.50.2500 Ms. Inge Forstenzer Ren-Pharm International, Ltd. 350 Jericho Turnpike, Suite 204 Jericho, NY 11753 RE: The tariff classification of Tramadol Hydrochloride (CAS-22204-88-2) in bulk form, from Italy Dear Ms. Forstenzer: In your letter dated July 30, 2008, you requested a tariff classification ruling. The subject product, Tramadol Hydrochloride, is an analgesic and is indicated for the management of moderate to severe pain. The applicable subheading for the Tramadol Hydrochloride in bulk form will be 2922.50.2500, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Oxygen-function amino-compounds: Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function: Aromatic: Other: Drugs: Other: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Vilanterol Trifenatate (CAS No. 503070-58-4) in bulk powder form and Umeclidinium Bromide (CAS No. 869113-09-7) in bulk powder form, from India
The tariff classification of Salmeterol Xinafoate (CAS No. 94749-08-3) in bulk power form, from Spain
The tariff classification of Albuterol Sulfate (CAS No. 51022-70-9) in bulk powder form, from Italy
The tariff classification of Droxydopa (CAS 23651-95-8) in bulk powder form, from Italy
The tariff classification of Bromfenac Sodium (CAS-126038-55-3), imported in bulk powder form, from Italy
The tariff classification of Mesalamine (CAS-89-57-6) in bulk form, from Italy
The tariff classification of Nepafenac (CAS-78281-72-8); Posaconazole (CAS-171228-49-2) and Bromfenac Sodium (CAS-91714-93-1) in bulk powder form, from Italy
The tariff classification of Fesoterodine Fumarate (CAS-286930-03-8) in bulk form, from Spain
The tariff classification of Nomegesterol Acetate (CAS-58652-20-3) and Venlafaxine Hydrochloride (CAS-99300-78-4) in bulk form, from Italy and China, respectively
The tariff classification of Mesalamine (CAS-89-57-6) in bulk form, from Italy
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →